Targeting the DNA-repair chromatin-modifier protein SMYD3 as a potential epigenetics-based therapy for gastric cancerKatia De Marco(University of Verona)IRIS Research product catalog (Sapienza University of Rome)February 19, 2026Cited by 0SaveCiteExport RISWatch citationsRelated PapersSMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer|Cells|2023|4